Chapter 9 References

Chakravarty, Debyani, Jianjiong Gao, Sarah Phillips, Ritika Kundra, Hongxin Zhang, Jiaojiao Wang, Julia E. Rudolph, et al. 2017. OncoKB: A Precision Oncology Knowledge Base.” JCO Precision Oncology, no. 1 (November): 1–16.
Chen, Siwei, Laurent C. Francioli, Julia K. Goodrich, Ryan L. Collins, Masahiro Kanai, Qingbo Wang, Jessica Alföldi, et al. 2022. “A Genome-Wide Mutational Constraint Map Quantified from Variation in 76, 156 Human Genomes,” March.
Danos, Arpad M., Kilannin Krysiak, Erica K. Barnell, Adam C. Coffman, Joshua F. McMichael, Susanna Kiwala, Nicholas C. Spies, et al. 2019. “Standard Operating Procedure for Curation and Clinical Interpretation of Variants in Cancer.” Genome Medicine 11 (1).
Eric S. Lander, and, Lauren M. Linton, Bruce Birren, Chad Nusbaum, Michael C. Zody, Jennifer Baldwin, Keri Devon, et al. 2001. “Initial Sequencing and Analysis of the Human Genome.” Nature 409 (6822): 860–921.
Good, Benjamin M, Benjamin J Ainscough, Josh F McMichael, Andrew I Su, and Obi L Griffith. 2014. “Organizing Knowledge to Enable Personalization of Medicine in Cancer.” Genome Biology 15 (8).
Hanahan, Douglas, and Robert A. Weinberg. 2011. “Hallmarks of Cancer: The Next Generation.” Cell 144 (5): 646–74.
Horak, Peter, Malachi Griffith, Arpad M. Danos, Beth A. Pitel, Subha Madhavan, Xuelu Liu, Cynthia Chow, et al. 2022. “Standards for the Classification of Pathogenicity of Somatic Variants in Cancer (Oncogenicity): Joint Recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC).” Genetics in Medicine 24 (5): 986–98.
Ley, Timothy J., Elaine R. Mardis, Li Ding, Bob Fulton, Michael D. McLellan, Ken Chen, David Dooling, et al. 2008. DNA Sequencing of a Cytogenetically Normal Acute Myeloid Leukaemia Genome.” Nature 456 (7218): 66–72.
Li, Marilyn M., Michael Datto, Eric J. Duncavage, Shashikant Kulkarni, Neal I. Lindeman, Somak Roy, Apostolia M. Tsimberidou, et al. 2017. “Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer.” The Journal of Molecular Diagnostics 19 (1): 4–23.
Mateo, J., D. Chakravarty, R. Dienstmann, S. Jezdic, A. Gonzalez-Perez, N. Lopez-Bigas, C. K. Y. Ng, et al. 2018. “A Framework to Rank Genomic Alterations as Targets for Cancer Precision Medicine: The ESMO Scale for Clinical Actionability of Molecular Targets (ESCAT).” Annals of Oncology 29 (9): 1895–1902.
Mughal, T. I., J. P. Radich, M. W. Deininger, J. F. Apperley, T. P. Hughes, C. J. Harrison, C. Gambacorti-Passerini, G. Saglio, J. Cortes, and G. Q. Daley. 2016. “Chronic Myeloid Leukemia: Reminiscences and Dreams.” Haematologica 101 (5): 541–58.
Rowley, Janet D. 1973. “A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia Identified by Quinacrine Fluorescence and Giemsa Staining.” Nature 243 (5405): 290–93.
Tan, Adrian, Gonçalo R. Abecasis, and Hyun Min Kang. 2015. “Unified Representation of Genetic Variants.” Bioinformatics 31 (13): 2202–4.